Front Row Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Front Row Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$67.4 - $85.11 $1,078 - $1,361	-16 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$76.01 - $99.03 $1,216 - $1,584	16 New	16 $2,000
Q1 2018 May 21, 2018	SELL	$77.67 - $92.63 $617,554 - $736,501	-7,951 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$80.76 - $95.13 $642,122 - $756,378	7,951	7,951 $709,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.